99Tcm-Cys-AnnexinV labeled compound with phosphatidylserine as target spot and labeling process and application thereof
A technology of 99tcm-cys-annexinv and phosphatidylserine, which is applied in the direction of radioactive physical shape and radioactive carrier, can solve the problems of increased radioactive uptake in the liver and the influence of AnnexinV activity, and achieves rapid liver and kidney clearance, which is conducive to clinical transformation and labeling The effect of the simple and easy process
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0039] Embodiment 1. Cys-AnnexinV 99 Tc m Marking technology
[0040] Cys-AnnexinV is provided by the State Key Laboratory of Medical Biotechnology of Nanjing University. It uses genetic engineering technology to clone, express and purify in Escherichia coli, and adds a cysteine with a sulfhydryl group to the carboxyl end of Annexin V, and uses a metal affinity layer. Analysis and purification, recombinant preparation of Cys-AnnexinV. It can be prepared by referring to the method disclosed in the Chinese patent application No. 201110072451.2 entitled "Human Annexin V variant and its expression, preparation and application".
[0041] Cys-AnnexinV was detected by direct labeling method 99 Tc m mark. Take an appropriate amount of SnCl 2 2H 2 O, dissolved in HCl with a concentration of 0.05mol / L, and diluted to 1mg / mL with pH7.4 phosphate buffer. Take the prepared SnCl-containing 2 30μL of citric acid buffer solution, add Cys-AnnexinV 5~10μg, shake well, and then add ...
Embodiment 2
[0044] Embodiment 2. 99 Tc m The biodistribution characteristics of the -Cys-AnnexinV-labeled compound meet the requirements for imaging agents, and are illustrated by organ distribution experiments in mice.
[0045] 40 Kunming mice were randomly divided into 8 groups with 5 mice in each group. tail vein injection 99 Tc m -Cys-AnnexinV at a dose of 11.1MBq in a volume of 0.2mL. A group of animals were executed at 6 time points of 5min, 30min, 1h, 2h, 4h, and 6h after administration, and blood, heart, liver, spleen, lung, kidney, stomach, small intestine, brain, muscle, and bone were taken out. Organs were weighed and radioactive counts were determined, and the time radioactive curves of each organ were drawn; the percent injection dose rate per gram of tissue was calculated (%ID / g, radioactive count per gram of tissue or organ / total radioactive count injected into mice ×100%). The blood clearance curve was drawn with time as the abscissa and radioactive count as the ordi...
Embodiment 3
[0049] Embodiment 3. 99 Tc m -Application of a Cys-AnnexinV labeled compound as an imaging agent for detecting cell apoptosis.
[0050] The technical scheme of the present invention is 99 Tc m -Application of Cys-AnnexinV labeled compound as imaging agent for detecting cell apoptosis. The aforementioned apoptosis can theoretically be the apoptosis process of any normal or diseased tissue cells in the organism, such as cardiomyocytes, tumor cells, etc. In the following, the cardiomyocyte apoptosis, tumor cell apoptosis and platelet activation caused by ischemia-reperfusion-acute myocardial infarction and tumor chemotherapy are taken as examples to illustrate.
[0051] 1. 99 Tc m -Cys-AnnexinV labeled compound as imaging agent to detect cardiomyocyte apoptosis
[0052] Six experimental minipigs (provided by the Experimental Animal Center of Nanjing Military General Hospital), weighing 15-20 Kg, were anesthetized by intramuscular injection of 10 mg / Kg of ketamine hydrochlo...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 